Aggregate amount of sales milestone.

No definition available.

Name:	lab_AggregateAmountOfSalesMilestone
Namespace Prefix:	lab_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Number of sales milestones.

+ References

No definition available.

+ Details

Name:	lab_NumberOfSalesMilestones
Namespace Prefix:	lab_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	instant

- Definition

Repurchase of common stock shares for litigation settlement.

+ References

No definition available.

+ Details

Name:	lab_RepurchaseOfCommonStockSharesForLitigationSettlement
Namespace Prefix:	lab_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

Settled outstanding litigation.

+ References

No definition available.

+ Details

Name:	lab_SettledOutstandingLitigation
Namespace Prefix:	lab_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

Settlement of outstanding litigation.

+ References

No definition available.

+ Details

Name:	lab_SettlementOfOutstandingLitigation
Namespace Prefix:	lab_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 842
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 7A
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 842
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478964/842-20-50-3

+ Details

Name:	us-gaap_LesseeLeaseDescriptionLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount of loss from litigation settlement for amount awarded to other party. Excludes claims within an insurance entity's normal claims settlement process.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483076/450-20-50-1

+ Details

Name:	us-gaap_LitigationSettlementLoss
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

The amount of cash paid for the settlement of litigation or for other legal issues during the period.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 45
-Paragraph 25
-Subparagraph (g)
-SubTopic 10
-Topic 230
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482740/230-10-45-25

+ Details

Name:	us-gaap_PaymentsForLegalSettlements
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Price of a single share of a number of saleable stocks of a company.

+ References

No definition available.

+ Details

Name:	us-gaap_SharePrice
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	instant

- Details

Name:	us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=lab_PalamedrixMergerAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Commitments and Contingencies - Narrative (Details) $ / shares in Units, $ in Millions		1 Months Ended		12 Months Ended
	Jul. 03, 2025 USD ($) Milestone	May 31, 2024 USD ($) $ / shares shares	Feb. 29, 2024 shares	Dec. 31, 2024 USD ($)
Lessee, Lease, Description [Line Items]
Settled Outstanding Litigation \| shares			422,048
Settlement of outstanding litigation		$ 6.2
Repurchase of common stock shares for litigation settlement \| shares		1,840,000
Market price \| $ / shares		$ 2.4
Payment for litigation settlement		$ 1.8
Litigation loss				$ 0.6
Subsequent Event \| Palamedrix Merger Agreement
Lessee, Lease, Description [Line Items]
Number of sales milestone \| Milestone	3
Aggregate amount of sales milestone	$ 17.5